gimoti Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gimoti, and what generic alternatives are available?
Gimoti is a drug marketed by Evoke Pharma Inc and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.
This drug has ten patent family members in seven countries.
The generic ingredient in GIMOTI is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gimoti
A generic version of gimoti was approved as metoclopramide hydrochloride by TEVA on July 29th, 1985.
Summary for gimoti
International Patents: | 10 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Patent Applications: | 1,385 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in gimoti? | gimoti excipients list |
DailyMed Link: | gimoti at DailyMed |
Pharmacology for gimoti
Drug Class | Dopamine-2 Receptor Antagonist |
Mechanism of Action | Dopamine D2 Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for gimoti
Paragraph IV (Patent) Challenges for GIMOTI
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
GIMOTI | Metered Nasal Spray | metoclopramide hydrochloride | 15 mg/spray | 209388 | 1 | 2021-12-30 |
US Patents and Regulatory Information for gimoti
gimoti is protected by four US patents.
Patents protecting gimoti
Nasal formulations of metoclopramide
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: NASAL ADMINISTRATION OF METOCLOPRAMIDE FOR TREATMENT OF DIABETIC GASTROPARESIS
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: NASAL ADMINISTRATION OF METOCLOPRAMIDE FOR TREATMENT OF DIABETIC GASTROPARESIS
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: NASAL ADMINISTRATION OF METOCLOPRAMIDE FOR TREATMENT OF DIABETIC GASTROPARESIS
Nasal formulations of metoclopramide
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: NASAL ADMINISTRATION OF METOCLOPRAMIDE FOR TREATMENT OF DIABETIC GASTROPARESIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Evoke Pharma Inc | GIMOTI | metoclopramide hydrochloride | SPRAY, METERED;NASAL | 209388-001 | Jun 19, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Evoke Pharma Inc | GIMOTI | metoclopramide hydrochloride | SPRAY, METERED;NASAL | 209388-001 | Jun 19, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Evoke Pharma Inc | GIMOTI | metoclopramide hydrochloride | SPRAY, METERED;NASAL | 209388-001 | Jun 19, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Evoke Pharma Inc | GIMOTI | metoclopramide hydrochloride | SPRAY, METERED;NASAL | 209388-001 | Jun 19, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for gimoti
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Evoke Pharma Inc | GIMOTI | metoclopramide hydrochloride | SPRAY, METERED;NASAL | 209388-001 | Jun 19, 2020 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for gimoti
See the table below for patents covering gimoti around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Cyprus | 1111396 | ⤷ Try a Trial | |
Denmark | 2376075 | ⤷ Try a Trial | |
Canada | 2403994 | ADMINISTRATION NASALE D'AGENTS POUR TRAITER LA GASTROPARESIE (NASAL ADMINISTRATION OF AGENTS FOR THE TREATMENT OF GASTROPARESIS) | ⤷ Try a Trial |
South Korea | 20030004361 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |